Inclusion Criteria:  confirmed treated or untreated renal cell carcinoma patients; 68Ga-PSMA PET/CT and 18F-FDG PET/CT within two weeks; signed written consent.  Exclusion Criteria:  pregnancy; breastfeeding; known allergy against PSMA any medical condition that in the opinion of the investigator may significantly interfere with study compliance